Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

Rhea-AI Summary

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) will participate in the virtual Capital One Spatial Biology & Proteomics Summit on September 28, 2022. Co-founder and CEO Sujal Patel is set to take part in two panel discussions: "Proteomics 'Everything You Wanted to Know, But Were Afraid to Ask'" at 11:30 a.m. ET / 8:30 a.m. PT, and a CEO panel at 1:00 p.m. ET / 10 a.m. PT. Interested attendees can register by contacting kristen.patrick@capitalone.com.

Nautilus is dedicated to advancing proteomics with a platform technology aimed at enhancing human health.

News Market Reaction – NAUT

-3.38%

-3.38% Session move

In the trading session that priced this news, NAUT declined 3.38%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEATTLE, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the upcoming Capital One Spatial Biology & Proteomics Summit taking place virtually on Wednesday, September 28, 2022.

Nautilus co-founder and CEO Sujal Patel is scheduled to participate in the following two executive panel discussions:

• Proteomics “Everything You Wanted to Know, But Were Afraid to Ask” at 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
• CEOs from Spatial Biology/Proteomics at 1:00 p.m. Eastern Time / 10 a.m. Pacific Time

Interested parties may contact kristen.patrick@capitalone.com to register to attend the virtual event.

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact
press@nautilus.bio

Investor Contact
investorrelations@nautilus.bio

FAQ

What is Nautilus Biotechnology's participation in the Capital One Summit?

Nautilus Biotechnology will participate in the Capital One Spatial Biology & Proteomics Summit virtually on September 28, 2022.

Who will represent Nautilus at the summit?

Co-founder and CEO Sujal Patel will represent Nautilus at the summit.

What panels will Sujal Patel participate in at the summit?

Sujal Patel will participate in two panels: 'Proteomics "Everything You Wanted to Know, But Were Afraid to Ask"' and a CEO panel on Spatial Biology/Proteomics.

What time are the discussions scheduled for at the Capital One Summit?

The discussions are scheduled for 11:30 a.m. ET and 1:00 p.m. ET on September 28, 2022.

How can interested parties register for the Capital One Summit?

Interested parties can register for the summit by contacting kristen.patrick@capitalone.com.